The key aim was to evaluate the efficacy of the vaccine vs . placebo in reducing cocaine use. Secondary targets bundled confirming vaccine immunogenicity via IgG anti-cocaine antibody degrees and evaluating the protection and tolerability of vaccination by way of a 20 week review and at 24 7 days comply https://kirka784yee1.theobloggers.com/profile